You need to enable JavaScript to run this app.
Quality considerations for generic drugs entering the Chinese market
RF Quarterly
Lixue Zhang, MS, RAC
Asia
Compliance
Generics
National Medical Products Administration (NMPA)
Product development
Quality Assurance and Control